Iparomlimab and Tuvonralimab Combined With Chemotherapy and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Clinical trial NCT07769853 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07769853
Sponsor: Zhejiang University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer (LARC)5-12cm to Anal Verge

Start date: 2026-09-01
Primary completion: 2027-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.